Patients

'Less about the product and more about the patient': Soundbites from Transforming Healthcare 2018

'Less about the product and more about the patient': Soundbites from Transforming Healthcare 2018

At MM&M's annual conference, panelists talked about how healthcare is moving toward value-based care and accelerating innovation

Interview | Rick Ford, TrialCard

Interview | Rick Ford, TrialCard

By

How can manufacturers of special medications drive better patient outcomes in an increasing complex environment? Rick Ford, Senior Director, Market Access Solutions at TrialCard, provides expertise and insights.

Evidence-based patient access programs

Evidence-based patient access programs

By

At the Asembia Specialty Pharma summit, speakers described a healthcare ecosystem in which specialty products will represent nearly half of all drug spending.

Interview | Paul LeVine, TrialCard

Interview | Paul LeVine, TrialCard

By

Paul LeVine, VP, Analytic Services for TrialCard, describes proven strategies that prevent patient adherence fall off, driven by evidenced-based design and patient engagement programs.

Drugs' value to patients eclipsed by price tags

Drugs' value to patients eclipsed by price tags

Like other sectors, pharma is experiencing upheavals no one predicted, and as a result, drugs are being reviled for their price tags, rather than praised for their value.

Health brands need to consider the human side of patients, HCPs, and stakeholders

Health brands need to consider the human side of patients, HCPs, and stakeholders

Croom Lawrence and Kent Groves of Merkle Health explain being human.

Can the healthcare industry really expect to drive patient engagement?

Can the healthcare industry really expect to drive patient engagement?

Increasing patient engagement as a tool for improving care and outcomes has been a tough code to crack for the healthcare industry.

PBMs, drugmakers face off over copay accumulators

PBMs, drugmakers face off over copay accumulators

By

As with most drug pricing battles, patients yet again are caught in the crossfire.

Standing out in the era of value-based healthcare marketing

Standing out in the era of value-based healthcare marketing

With healthcare evolving from a fee-for-service system toward one that bases payment on outcomes, marketers must speak to customers in value-oriented messages.

Infographic | AI's impact on patients and caregivers

Infographic | AI's impact on patients and caregivers

By

Caregivers and patients predict how the use of AI will affect them.

Will the real patient advocate please stand up?

Will the real patient advocate please stand up?

By

Industry opponents say the end is nigh for pharma's ability to deduct expenses for consumer drug advertising, but those who've found their calling in healthcare comms ought to have something to say about that.

6 Campaigns Driving Better Behavior

6 Campaigns Driving Better Behavior

More than ever, marketers and agencies have a powerful role in shaping public health, curbing harmful behaviors, and promoting good ones among at-risk communities and individuals.

Five things for pharma marketers to know: Thursday, January 18, 2018

Five things for pharma marketers to know: Thursday, January 18, 2018

By

Senate committee votes in favor of Azar as new HHS head; FDA and DoD launch breakthrough designation program; Walmart offers free opioid disposal solution

Can digital tools really change patient behavior?

Can digital tools really change patient behavior?

By

New research calls into question the behavioral effects of some digital health tools.

Five things for pharma marketers to know: Tuesday, January 9, 2018

Five things for pharma marketers to know: Tuesday, January 9, 2018

By

Shire considers splitting into two units; New Jersey finalizes physician-pharma gift limit; more biotech M&As expected in 2018

Cancer Research UK 'Right Now' campaign returns to highlight research impact

Cancer Research UK 'Right Now' campaign returns to highlight research impact

By

Cancer Research UK's 'Right Now' brand campaign will return in 2018 with a new focus highlighting the impact that research has on people suffering with cancer.

6 Campaigns that Talk to, Not at, Patients

6 Campaigns that Talk to, Not at, Patients

Rather than talking at them, we need to design with and for them.

Infographic | HCPs must deal with communication breakdown

Infographic | HCPs must deal with communication breakdown

Drugmakers are proud of the patient service programs they've developed. Yet there remains a disconnect in the way information is communicated to HCPs.

Five things for pharma marketers to know: Friday, December 8, 2017

Five things for pharma marketers to know: Friday, December 8, 2017

By

FDA approves first nebulized LAMA COPD treatment; more than 2,000 cancer immunotherapies in development; FDA issues 3D-printing guidance

 Five things for pharma marketers to know: Thursday, December 7, 2017

Five things for pharma marketers to know: Thursday, December 7, 2017

By

UnitedHealth Group to buy DaVita primary care unit for $4.9 billion; Roche drug combo doubles lung-cancer survival in trial; study: FDA programs expedite drug approval

Five things for pharma marketers to know: Tuesday, December 5, 2017

Five things for pharma marketers to know: Tuesday, December 5, 2017

By

Botox-like wrinkle-reducer shows positive results in trials; investors double down on fertility; few websites transparent about pricing, study finds

Five things for pharma marketers to know: Wednesday, November 29, 2017

Five things for pharma marketers to know: Wednesday, November 29, 2017

By

U.K. to be first to sell OTC Viagra; Regeneron offers startup scientific expertise; docs more likely to get poor marks when they reject patient requests

Five things for pharma marketers to know: Wednesday, October 18, 2017

Five things for pharma marketers to know: Wednesday, October 18, 2017

By

More than half of doctors say patients make critical, racist, or sexist comments; Anthem to launch its own PBM; drugmakers face criticism for waste

Five things for pharma marketers to know: Tuesday, October 10, 2017

Five things for pharma marketers to know: Tuesday, October 10, 2017

By

Patients complain about positive healthcare ads; some drugmakers skirt Open Payment rules; new law requires disclosure of drug price hikes in California

Online patient communities consider the platform: Facebook, or somewhere more private?

Online patient communities consider the platform: Facebook, or somewhere more private?

By

Facebook itself has more than six million health-related groups.

American Cancer Society: 'We are more than just a research organization'

American Cancer Society: 'We are more than just a research organization'

By

The new brand campaign, Attacking Cancer from Every Angle, showcases all the services the organization provides.

Five things for pharma marketers to know: Friday, September 1, 2017

Five things for pharma marketers to know: Friday, September 1, 2017

By

600 patients are eligible for CAR-T therapy; the FDA halts Keytruda combo study for multiple myeloma; the regulator delays decision on Herceptin biosimilar

Infographic | What patients want: a better healthcare experience

Infographic | What patients want: a better healthcare experience

By

Patients are demanding more of their healthcare experience — and that includes from their healthcare providers, according to two new surveys.

4 Ways Marketers Can Work With Advocacy Groups to Achieve Brand Objectives

4 Ways Marketers Can Work With Advocacy Groups to Achieve Brand Objectives

As the influence of patient communities and advocacy groups grows, how can marketers work these organizations to achieve brand objectives?

Drugmakers turn to tech to better demonstrate empathy

Drugmakers turn to tech to better demonstrate empathy

By

Frustrated by its inability to empathize with patients, pharma has turned to tech to teach providers and caregivers what illness really feels like.